(1-carbamoylcyclopropyl) 1-[3-[2-(oxan-4-ylamino)-4-pyridinyl]-2,6-naphthyridin-1-yl]piperidine-4-carboxylate
C28H32N6O4 — CID 90871316
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1-carbamoylcyclopropyl) 1-[3-[2-(oxan-4-ylamino)-4-pyridinyl]-2,6-naphthyridin-1-yl]piperidine-4-carboxylate
(1-carbamoylcyclopropyl) 1-[3-[2-(oxan-4-ylamino)-4-pyridinyl]-2,6-naphthyridin-1-yl]piperidine-4-carboxylate (PubChem CID 90871316) has the molecular formula C28H32N6O4 and a molecular weight of 516.60 g/mol. Its IUPAC name is (1-carbamoylcyclopropyl) 1-[3-[2-(oxan-4-ylamino)-4-pyridinyl]-2,6-naphthyridin-1-yl]piperidine-4-carboxylate.
Molecular Properties
| Compound Name | (1-carbamoylcyclopropyl) 1-[3-[2-(oxan-4-ylamino)-4-pyridinyl]-2,6-naphthyridin-1-yl]piperidine-4-carboxylate |
|---|---|
| PubChem CID | 90871316 |
| Molecular Formula | C28H32N6O4 |
| Molecular Weight | 516.60 g/mol |
| Exact Mass | 516.25 |
| IUPAC Name | (1-carbamoylcyclopropyl) 1-[3-[2-(oxan-4-ylamino)-4-pyridinyl]-2,6-naphthyridin-1-yl]piperidine-4-carboxylate |
| SMILES | NC(=O)C1(OC(=O)C2CCN(c3nc(-c4ccnc(NC5CCOCC5)c4)cc4cnccc34)CC2)CC1 |
| InChI | InChI=1S/C28H32N6O4/c29-27(36)28(7-8-28)38-26(35)18-3-11-34(12-4-18)25-22-2-9-30-17-20(22)15-23(33-25)19-1-10-31-24(16-19)32-21-5-13-37-14-6-21/h1-2,9-10,15-18,21H,3-8,11-14H2,(H2,29,36)(H,31,32) |
| InChIKey | JAHRNUWXPUICKJ-UHFFFAOYSA-N |
| XLogP | 3.06 |
| TPSA | 132.56 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 516.60 |
| LogP ≤ 5 | 3.06 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90871316 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.